Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nahéma Issa

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
La Revue Du Praticien|August 20, 2016
[Treatment of pneumonia]Fabrice Camou, Nahéma Issa
Annals of Hematology|July 19, 2020
Atypical presentation of a central nervous system aspergillosis in a peripheral T cell lymphoma patientMathieu Larroquette, Nahéma Issa, Frédéric Gabriel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2020
Reply to Pericàs et alRaphaël Lecomte, Nahéma Issa, Fabrice Camou, et al.
Multiple Sclerosis and Related Disorders|August 23, 2020
Severe anti-GFAP meningo-encephalomyelitis following viral infectionNahéma Issa, Clément Martin, Cécile Dulau, et al.
Infection|March 11, 2022
Pneumocystis in the era of prophylaxis: do the guidelines have to change?Julien Nunes, Nahéma Issa, Amandine Dupuis, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 22, 2019
What is the time-to-positivity of blood cultures in infective endocarditis?Olivia Peuchant, Nahéma Issa, Irène Machelart, et al.
Journal of Medical Virology|June 3, 2020
Feasibility of tocilizumab in ICU patients with COVID-19Nahéma Issa, Margot Dumery, Olivier Guisset, et al.
RMD Open|September 8, 2017
Treatment of polyarteritis nodosa with tocilizumab: a new therapeutic approach?Aurélie Saunier, Nahéma Issa, Marie-Anne Vandenhende, et al.
Infectious Diseases Now|December 18, 2021
Impact of extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) rectal carriage in cancer patients admitted to the intensive care unitNahéma Issa, Maider Coppry, Eva Ripoche, et al.
Journal of Clinical Medicine|January 8, 2023
Interest of a Commercialized <i>Pneumocystis jirovecii</i> Quantitative PCR to Discriminate Colonization from <i>Pneumocystis</i> Pneumonia according to the Revised EORTC/MSGERC CriteriaFlorian Lussac-Sorton, Tara Fleur, Thibault Voisin, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
La Revue Du Praticien|August 20, 2016
[Treatment of pneumonia]Fabrice Camou, Nahéma Issa
Annals of Hematology|July 19, 2020
Atypical presentation of a central nervous system aspergillosis in a peripheral T cell lymphoma patientMathieu Larroquette, Nahéma Issa, Frédéric Gabriel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2020
Reply to Pericàs et alRaphaël Lecomte, Nahéma Issa, Fabrice Camou, et al.
Multiple Sclerosis and Related Disorders|August 23, 2020
Severe anti-GFAP meningo-encephalomyelitis following viral infectionNahéma Issa, Clément Martin, Cécile Dulau, et al.
Infection|March 11, 2022
Pneumocystis in the era of prophylaxis: do the guidelines have to change?Julien Nunes, Nahéma Issa, Amandine Dupuis, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 22, 2019
What is the time-to-positivity of blood cultures in infective endocarditis?Olivia Peuchant, Nahéma Issa, Irène Machelart, et al.
Journal of Medical Virology|June 3, 2020
Feasibility of tocilizumab in ICU patients with COVID-19Nahéma Issa, Margot Dumery, Olivier Guisset, et al.
RMD Open|September 8, 2017
Treatment of polyarteritis nodosa with tocilizumab: a new therapeutic approach?Aurélie Saunier, Nahéma Issa, Marie-Anne Vandenhende, et al.
Infectious Diseases Now|December 18, 2021
Impact of extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) rectal carriage in cancer patients admitted to the intensive care unitNahéma Issa, Maider Coppry, Eva Ripoche, et al.
Journal of Clinical Medicine|January 8, 2023
Interest of a Commercialized <i>Pneumocystis jirovecii</i> Quantitative PCR to Discriminate Colonization from <i>Pneumocystis</i> Pneumonia according to the Revised EORTC/MSGERC CriteriaFlorian Lussac-Sorton, Tara Fleur, Thibault Voisin, et al.
Pageof 4